Search
01/09/2024
A tool for Dravet syndrome-associated neuropsychiatric comorbidities evaluation (DANCE)
Giorgi, S, Auvin, S, Schoonjans, AS, Turón, E, Sánchez-Miranda, I, Gil-Nagel, A, Lagae, L, Aibar, JA. A tool for Dravet syndrome-associated neuropsychiatric comorbidities evaluation (DANCE). EPILEPSY & BEHAVIOR. 2024; 158DOI:10.1016/j.yebeh.2024.109958. PMID:39067307. IF:2.300(Q2/4D).
01/09/2024
Role of Venous Delay on Stroke Outcome: Prospective Evaluation Before and After Mechanical Thrombectomy
Zangana, L, Valls, A, Munuera, J, Werner, M, Remollo, S, Dorado, L, Serena, J, Puig, J, de la Ossa, NP, Gomis, M, Bustamante, A, Pina, BF, Martinez, M, Castaño, C, Muñoz, L, Massuet, A, Coutinho, JM, Millán, M, Hernández-Pérez, M. Role of Venous Delay on Stroke Outcome: Prospective Evaluation Before and After Mechanical Thrombectomy. Journal of Stroke. 2024; 26(3)DOI:10.5853/jos.2024.00150. PMID:39223974. IF:8.600(Q1/1D).
01/09/2024
Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels
Ferre-Giraldo, A, Castells, M, Sánchez-Herrero, JF, López-Rodrigo, O, de Rocco-Ponce, M, Bassas, L, Vigués, F, Sumoy, L, Larriba, S. Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(18)DOI:10.3390/ijms251810122. PMID:39337607. IF:4.900(Q1/3D).
01/09/2024
Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease
Ben-Aicha, S, Anwar, M, Vilahur, G, Martino, F, Kyriazis, PG, de Winter, N, Punjabi, PP, Angelini, GD, Sattler, S, Emanueli, C. Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease. Jacc-Basic To Translational Science. 2024; 9(9)DOI:10.1016/j.jacbts.2024.05.003. PMID:39444932. IF:7.200(Q1/2D).
01/09/2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study
de Isla, LP, Vallejo-Vaz, AJ, Watts, GF, Muñiz-Grijalvo, O, Alonso, R, Diaz-Diaz, JL, Arroyo-Olivares, R, Aguado, R, Argueso, R, Mauri, M, Romero, MJ, Alvarez-Baños, P, Mañas, D, Cepeda, JM, Gonzalez-Bustos, P, Casañas, M, Michan, A, Muñoz-Torrero, JFS, Faedo, C, Barba, MA, Dieguez, M, de Andrés, R, Hernandez, AM, Gonzalez-Estrada, A, Padró, T, Fuentes, F, Badimon, L, Mata, P. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study. Lancet Diabetes & Endocrinology. 2024; 12(9)DOI:10.1016/S2213-8587(24)00192-X. PMID:39098315. IF:41.800(Q1/1D).
01/09/2024
Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis
Fernandez-Bravo, S, Canyelles, M, Martín-Blázquez, A, Borràs, C, Nuñez-Borque, E, Palacio-García, L, Del Rio, PR, Betancor, D, Gómez-López, A, Brescó, MS, Laguna, JJ, Méndez-Barbero, N, Rotllan, N, Escolà-Gil, JC, Esteban, V. Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024; 154(3)DOI:10.1016/j.jaci.2024.03.031. PMID:38718948. IF:11.200(Q1/1D).
01/09/2024
Serum calprotectin in severe and mild COVID-19 patients
Agulló, GJ, Aragon, MP, de la Poza, JFD, Alcorisa, SV. Serum calprotectin in severe and mild COVID-19 patients. EUROPEAN JOURNAL OF IMMUNOLOGY. 2024; 54DOI:. PMID:. IF:3.700(Q2/5D).
01/09/2024
Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period
Somolinos-Simón, FJ, García-Sáez, G, Tapia-Galisteo, J, Corcoy, R, Hernando, ME. Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 215DOI:10.1016/j.diabres.2024.111803. PMID:39089589. IF:7.400(Q1/1D).
01/09/2024
Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy
Cheng, A, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, M, Bonnemaire, M, Lydie, MM, Mimouni, S, Davies, M. Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation
Claramunt, FC, Lazaro, D, Salter, J, Paldánius, P, Mauricio, D. Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study
Torre, ELM, Alarcón, PP, Rodríguez, MM, Serrallonga, NB, Palomar, JR, Iglesias, DM, Hoyas, CN, Servat, OS, Kyriakos, G, Bellas, LC, Pla, RC, Ramonde, TM, López, ML, Madorell, BS, Borrás, JG. Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects
Rosales, A, Gil, P, Julian, T, Teis, A, Pedraz, B, Sanchez, J, Julve, J, Mauricio, D, Perez, A, Alonso, N. Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024)
Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Hualpa, JCP, Garcia-Centeno, R, Gonzalez-Fernandez, L, Garcia, MDO, Echarri, AI, Rodriguez, MDM, Novo-Rodriguez, C, Calatayud, M, Villar-Taibo, R, Bernabeu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenez, C, Galiana, PA, Venegas, E, Gonzalez-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Cordova, JM, Aviles-Perez, MD, Asensio-Wandosell, D, Sampedro-Nunez, M, Camara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024). ENDOCRINE-RELATED CANCER. 2024; 31(9)DOI:10.1530/ERC-24-0043e. PMID:. IF:4.600(Q1/3D).
01/09/2024
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial
Ortiz, O, Daca-Alvarez, M, Rivero-Sanchez, L, Gimeno-Garcia, AZ, Carrillo-Palau, M, Alvarez, V, Ledo-Rodriguez, A, Ricciardiello, L, Pierantoni, C, Hüneburg, R, Nattermann, J, Bisschops, R, Tejpar, S, Huerta, A, Pons, FR, Alvarez-Urturi, C, López-Vicente, J, Repici, A, Hassan, C, Cid, L, Cavestro, GM, Romero-Mascarell, C, Gordillo, J, Puig, I, Herraiz, M, Betes, M, Herrero, J, Jover, R, Balaguer, F, Pellisé, M. An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial. Lancet Gastroenterology & Hepatology. 2024; 9(9)DOI:10.1016/S2468-1253(24)00187-0. PMID:39033774. IF:38.600(Q1/1D).
01/09/2024
Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors
Ollivier-Hourmand, I, Lebedel, L, Alabau, BB, Goria, O, Bureau, C, Dumortier, J, Heurgue, A, Silvain, C, De-Ledinghen, V, Rautou, PE, Payance, A, Ballester, TG, Alvarado-Tapias, E, Hernandez-Gea, V, Valla, D, Zekrini, K, Nguyen, TTN, Dao, T, Pagan, JCG, Morello, R, Plessier, A. Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors. JOURNAL OF HEPATOLOGY. 2024; 81(3)DOI:10.1016/j.jhep.2024.04.016. PMID:38679069. IF:33.000(Q1/1D).
01/09/2024
Ultrasound in Rheumatology, It is a Must
Corominas, H, Badlissi, F. Ultrasound in Rheumatology, It is a Must. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2024.250324. PMID:39308354. IF:(Q/D).
01/09/2024
Ultrasound for the Diagnosis of Giant Cell Arteritis
Alarcón, PVE, Alvarado, PM, Alierta, ELS. Ultrasound for the Diagnosis of Giant Cell Arteritis. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2024.20104. PMID:39311386. IF:(Q/D).
01/09/2024
SSc-PAH patients are at risk of disease progression in contemporary clinical practice
Bjorkekjær, HJ, Bruni, C, Brunborg, C, Carreira, P, Airò, P, Simeón-Aznar, CP, Truchetet, ME, Giollo, A, Balbir-Gurman, A, Martin, M, Denton, CP, Gabrielli, A, Fretheim, H, Bitter, H, Midtvedt, O, Broch, K, Andreassen, A, Hoie, S, Tanaka, Y, Riemekasten, G, Müller-Ladner, U, Matucci-Cerinic, M, Castellví, I, Siegert, E, Hachulla, E, Molberg, O, Distler, O, Hoffmann-Vold, AM. SSc-PAH patients are at risk of disease progression in contemporary clinical practice. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2493. PMID:. IF:21.000(Q1/1D).
01/09/2024
ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis
De Miguel, E, Hern ndez-Rodr guez, I, Silva-Diaz, M, Belzunegui, JM, Moya, P, Tortosa-Caba as, M, Navarro, VA, Calvet, J, Casafont-Sol , I, Rom n-Ivorra, JA, Labrada-Arrabal, S, Rocha, MV, I iguez, CL, Hern ndez-Hern ndez, V, Campos-Fern ndez, C, Villar, MA, Juan-Mas, A, Prado-Galbarro, FJ, Calvo, I, S nchez-Mart n, J, Narvaez-Garc a, J, Blanco-Alonso, R. ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study
Narvaez-Garc a, J, Llobell, A, Ponce, A, Gomez-Centeno, A, Mill n, AM, Corominas, H, Nolla, JM, Gomez-Puerta, JA. Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).